Stay updated on Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.

Latest updates to the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision label updated from v3.5.3 to v3.5.4, indicating a minor update to the page framework without changes to study content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page footer revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor ClinicalTrials.gov site release.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check59 days agoChange DetectedThe condition name was changed from 'Neuroendocrine pancreatic tumor' to 'Neuroendocrine tumor of pancreas' in the study's conditions section.SummaryDifference0.1%

- Check66 days agoChange DetectedCarcinoid tumor keyword added and page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.4.3 is displayed and Revision: v3.4.2 has been removed.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.